SWI/SNF chromatin remodeling complexes and cancer
JA Biegel, TM Busse… - American Journal of …, 2014 - Wiley Online Library
The identification of mutations and deletions in the SMARCB1 locus in chromosome band
22q11. 2 in pediatric rhabdoid tumors provided the first evidence for the involvement of the …
22q11. 2 in pediatric rhabdoid tumors provided the first evidence for the involvement of the …
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
C O'Keefe, MA McDevitt… - Blood, The Journal of …, 2010 - ashpublications.org
Single nucleotide polymorphism arrays (SNP-A) have recently been widely applied as a
powerful karyotyping tool in numerous translational cancer studies. SNP-A complements …
powerful karyotyping tool in numerous translational cancer studies. SNP-A complements …
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Genomic studies have revealed the complex clonal heterogeneity of chronic lymphocytic
leukemia (CLL). The acquisition and selection of genomic aberrations may be critical to …
leukemia (CLL). The acquisition and selection of genomic aberrations may be critical to …
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
M Duvic, R Talpur, X Ni, C Zhang, P Hazarika, C Kelly… - Blood, 2007 - ashpublications.org
The activity and safety of the histone deacetylase inhibitor vorinostat (suberoylanilide
hydroxamic acid, SAHA) were evaluated in patients with refractory cutaneous T-cell …
hydroxamic acid, SAHA) were evaluated in patients with refractory cutaneous T-cell …
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia
Context Chromosomal abnormalities (namely 13q, 17p, and 11q deletions) have prognostic
implications and are recurrent in chronic lymphocytic leukemia (CLL), suggesting that they …
implications and are recurrent in chronic lymphocytic leukemia (CLL), suggesting that they …
Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution
Patients with chromosome 13q deletion or normal cytogenetics represent the majority of
chronic lymphocytic leukaemia (CLL) cases, yet have relatively few driver mutations. To …
chronic lymphocytic leukaemia (CLL) cases, yet have relatively few driver mutations. To …
Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and …
C Haferlach, F Dicker, S Schnittger, W Kern… - Leukemia, 2007 - nature.com
In CLL data from chromosome banding analysis (CBA) have been scarce due to the low
proliferative activity of CLL cells in vitro. We improved the cultivation technique using an …
proliferative activity of CLL cells in vitro. We improved the cultivation technique using an …
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia
MC Di Bernardo, D Crowther-Swanepoel, P Broderick… - Nature …, 2008 - nature.com
We conducted a genome-wide association study of 299,983 tagging SNPs for chronic
lymphocytic leukemia (CLL) and performed validation in two additional series totaling 1,529 …
lymphocytic leukemia (CLL) and performed validation in two additional series totaling 1,529 …
Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia
CJ Ott, AJ Federation, LS Schwartz, S Kasar… - Cancer cell, 2018 - cell.com
Enhancer profiling is a powerful approach for discovering cis-regulatory elements that define
the core transcriptional regulatory circuits of normal and malignant cells. Gene control …
the core transcriptional regulatory circuits of normal and malignant cells. Gene control …
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML
Using metaphase cytogenetics (MC), chromosomal abnormalities are found in only a
proportion of patients with myelodysplastic syndrome (MDS). We hypothesized that with new …
proportion of patients with myelodysplastic syndrome (MDS). We hypothesized that with new …